key: cord-0990033-cz05jb6e
authors: Lu, Ping-Hsun; Tseng, Chien-Wei; Lee, Jing-Ling; Lee, En-Yu; Lin, Yu-Ping; Lin, I-Hsin; Yu, Min-Chien; Lu, Kuo-Cheng; Kuo, Ko-Lin
title: Jing Si Herbal Drink as a Prospective Adjunctive Therapy for COVID-19 Treatment: Molecular evidence and mechanisms
date: 2021-12-09
journal: Pharmacological Research - Modern Chinese Medicine
DOI: 10.1016/j.prmcm.2021.100024
sha: eae604436c7fc9784db9faec5e74097f3c7c0fad
doc_id: 990033
cord_uid: cz05jb6e

Background : SARS-CoV-2 has led to a sharp increase in the number of hospitalizations and deaths from pneumonia and multiorgan disease worldwide; therefore, SARS-CoV-2 has become a global health problem. Supportive therapies remain the mainstay treatments against COVID-19, such as oxygen inhalation, antiviral drugs, and antibiotics. Traditional Chinese medicine (TCM) has been shown clinically to relieve the symptoms of COVID-19 infection, and TCMs can affect the pathogenesis of SARS-CoV-2 infection in vitro. Jing Si Herbal Drink (JSHD), an eight herb formula jointly developed by Tzu Chi University and Tzu Chi Hospital, has shown potential as an adjuvant treatment for COVID-19 infection. A randomized controlled trial (RCT) of JSHD as an adjuvant treatment in patients with COVID-19 infection is underway Objectives : This article aims to explore the efficacy of the herbs in JSHD against COVID-19 infection from a mechanistic standpoint and provide a reference for the rational utilization of JSHD in the treatment of COVID-19. Method : We compiled evidence of the herbs in JSHD to treat COVID-19 in vivo and in vitro. Results : We described the efficacy and mechanism of action of the active ingredients in JSHD to treat COVID-19 based on experimental evidence. JSHD includes 5 antiviral herbs, 7 antioxidant herbs, and 7 anti-inflammatory herbs. In addition, 2 herbs inhibit the overactive immune system, 1 herb reduces cell apoptosis, and 1 herb possesses antithrombotic ability. Conclusion : Although experimental data have confirmed that the ingredients in JSHD are effective against COVID-19, more rigorously designed studies are required to confirm the efficacy and safety of JSHD as a COVID-19 treatment.

Coronaviruses (CoVs) were first isolated in 1962 and are known to cause mild 125 respiratory and gastrointestinal infections in humans and animals [1] . Two viruses of 126 zoonotic origin, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East 127 respiratory syndrome coronavirus (MERS-CoV), are causative agents of fatal infections of the 128 lower respiratory tract [2] . The discovery of SARS-CoV-2 in 2019 was regarded as the third 129 jump of coronaviruses from animals to humans [1] . An to the angiotensin-converting enzyme 2 (ACE2) receptor, which is broadly distributed on 139 different tissues and immune cells [4] . COVID-19 infection may be asymptomatic, may cause 140 a wide spectrum of mild clinical manifestations, such as fever, cough, sore throat, fatigue, 141 and myalgia, or may cause life-threatening pneumonia, acute respiratory distress syndrome 142 (ARDS), multiorgan injury, and sepsis [3, 4] . Multiple studies have determined that the 7 severity of SARS-CoV-2 infection is correlated with the excessive activation of immune cells 144 and overproduction of inflammatory cytokines, known as a cytokine storm, which is fast-145 developing and causes life-threatening immunopathological damage. Cytokine storms have 146 been implicated in poor clinical outcomes, including ARDS, disseminated intravascular 147 coagulation (DIC), hemophagocytic lymphohistiocytosis (HLH), multiorgan injury, and even 148 death if no adequate therapies are available [4] . 149

At present, general and rapid global vaccination has been a major strategy against the 150 dramatic physiological imbalance caused by SARS-CoV-2 infection and the most effective 151 method for resolving long-term pandemics worldwide [1] . However, alterations of the spike 152 residues within major epitopes may affect antibody binding and neutralization, which 153 further mitigates the efficiency of antibodies produced by vaccination or natural infection 154 [1] . To date, four globally recognized COVID-19 variants have been labeled "variants of 155 concern" (VOC), including Alpha/B.1.1.7, Beta/B.1.351, Gamma/P.1 and Delta/B.1.617. 2, 156 which exhibit higher transmissibility and morbidity/mortality and a significant decrease in 157 the effectiveness of neutralization by antibodies elicited by infection, vaccination, or 158 therapeutic application [1] . Thus, apart from vaccination, it is essential to have adjunctive 159 therapies that could suppress the invasion of SARS-CoV-2 into human cells, obstruct viral 160 replication and prevent the overproduction of inflammatory cytokines triggered by viral 161 infection. 162

Chinese herbs as remedial measures against different diseases have been accepted 163 because of certain beneficial characteristics, such as fewer side effects, easy availability, and 164 cost-effectiveness [5] . Emerging evidence reports that Chinese herbs have shown 165 remarkable successes in coping with the pathogenic pathways of SARS-CoV-2 infection. For 166 example, curcumin can bind to a receptor-binding domain (RBD) of the spike protein, 167 nucleocapsid protein, and membrane glycoprotein of SARS-CoV-2 to inhibit viral replication 168 through the phosphoinositide 3-kinase (PI3K)/Akt and nuclear factor kappa B (NF-kB) 169 pathways [5] . Glycyrrhizin binds to the ACE2 receptor, inhibits thrombin, and alleviates 170 airway exudates [5] . Lianhua Qingwen capsule was found to suppress SARS-CoV-2 replication 171 in a dose-dependent manner [6, 7] . The ingredients of Qingfei Paidu decoction can restrain 172 cytokine release and diminish excessive immune responses and inflammation by modulating 173 AKT serine/threonine kinase 1 (AKT1), mitogen-activated protein kinase (MAPK)-1, MAPK3, 174 MAPK8, MAPK14, interleukin (IL)-6, RELA, signal transducer and activator of transcription 175 signaling pathways, NF-κB, MAPK, vascular endothelial growth factor (VEGF), hypoxia-178 inducible factor 1 (HIF-1) and Toll-like receptor (TLR) signaling pathways [7] 

206 of COVID-19 infection in detail. SARS-CoV-2 is a single-stranded positive-sense RNA virus 208 containing four major structural proteins, including spike (S), envelope (E), membrane 209 protein (M), and nucleocapsid (N), all of which are required to constitute a structurally 210 complete viral particle [12] . The RBD on the spike proteins facilitates SARS-CoV-2 access to 211 human lung, heart, and kidney cells by binding to the ACE2 receptor on the host cells 212 [13, 14] , and neutralizing antibodies against the RBD are important for immunity [15] . SARS-213

CoV-2 enters human cells by the endocytic pathway, and subsequently, cathepsin B/L 214 mediates cleavage of the S protein in lysosomes [16] . Furthermore, fusion of the viral 215 envelope with the host plasma membrane aids in SARS-CoV-2 access to human cells, where 216 transmembrane serine protease 2 (TMPRSS2) mediates cleavage of the S protein [16] . 217

Cleavage of the S protein by cathepsin B/L and/or TMPRSS2 further facilitates the release of 218 viral RNA in the cytosol of host cells [16] . Therefore, host cells are susceptible to SARS-CoV-2 219 depending on the abundance and availability of the host proteases cathepsin B/L and 220 TMPRSS2 as well as ACE2 receptors. SARS-CoV-2 binding to ACE2 results in a decrease in 221 ACE2 [17] , impeding downstream angiotensin-II (Ang-II) metabolism and eventually leading 222

to Ang-II accumulation [13] . This increase in Ang-II causes pulmonary vasoconstriction, acute 223 lung injury, lung edema, and lung fibrosis [13, 18-20] 224 After entry into human cells, SARS-CoV-2 releases genomic RNA. The viral genome 225 encodes two polyproteins, pp1a and pp1ab, which are cleaved into the main protease 226 (Mpro) and 16 nonstructural proteins (Nsps). Mpro plays a crucial role in the production of 227

Nsps. Six Nsps, including NSP3, NSP9, NSP10, NSP12, NSP15, and NSP16, are responsible for 228 the collection of replication transcription complexes (RTCs) to execute RNA replication [21] . 229 N proteins bind to SARS-CoV-2 genomic RNA to form helical ribonucleoprotein (RNP) 230 complexes together with M proteins to facilitate new intact virions [22] , which are ultimately 231 released from human cells. 232 233

NF-κB is a pleiotropic transcription factor that is responsible for the transcriptional 235 activities of various genes involved in immune functions and inflammatory responses. NF-κB 236 mediates the survival, activation, and differentiation of innate immune cells, including 237 macrophages, dendritic cells, neutrophils, and T cells [23] . These innate immune cells 238 express pattern recognition receptors (PRRs) that recognize various pathogen-associated 239 molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) released 240 by necrotic cells and damaged tissues [23] . The signaling pathways of PRR-activated innate 241 immune cells are associated with NF-κB regulation, which controls the transcriptional 242 expression of proinflammatory cytokines, chemokines, and additional inflammatory 243 mediators [23] . These inflammatory mediators can elicit inflammation and indirectly activate 244 the differentiation of T cells [23] . Severe COVID-19 causes hypercytokinemia via macrophage 245 activation within the lung and ultimately progresses to organ failure [24] . Upregulated Ang-II 246 binding to the angiotensin II type I receptor (AT1R) promotes NF-κB and macrophage 247 activation, further inducing cytokine release [13, 23] . The upregulation of proinflammatory 248 cytokines, such as TNF-α, IL-6, and IL-1β, induced by microphage activation is called a 249 cytokine storm, which contributes to acute respiratory distress syndrome (ARDS) [13] . 250

Moreover, SARS-CoV-2 affects the natural killer (NK) and CD8+ cell populations, leading to 251 reduced production of anti-inflammatory cytokines, including interferon (IFN)-α and IFN-γ, 252

and increased levels of pro-inflammatory cytokines [5] . 253 HMGB1 is one of the major downstream DAMPs in the NLRP3 activation pathway and it 268 was originally found after endotoxin lethality in mice [26] . It is also a late marker of lethal 269 systemic inflammation [27] , and infection correlates with epithelial barrier failure, organ 270 crucial role in intense inflammatory responses and pathological severity during viral 272 infection [29, 30] . Infection or injury elevates the levels of HMGB1 in the lungs in influenza 273 virus and acute lung injury models, which results in pneumonia and even death; however, 274 these phenomena can be inhibited by the administration of HMGB1-specific antibodies 275 [30, 31] . infection have a significantly higher number of CC chemokine receptor (CCR)-6+ Th17 cells in 301 peripheral blood, which further supports Th17 responses in cytokine storms [40] . Taken 302 together, these findings may be associated with the release of proinflammatory cytokines by 12 innate immune cells, further sparking the cytokine storm and eventually organ injury 304 [34, 40] . oxide synthase (iNOS). Nitrogen monoxide (NO) derived from iNOS is involved in the 325 regulation of the immune system [44] and is correlated with tissue damage [45] . iNOS has 326 been found in various types of immune cells during inflammation, including macrophages, 327 neutrophils, eosinophils, and airway epithelial cells [46, 47] . Moreover, the inhibition of iNOS 328 attenuates neutrophil and macrophage infiltration [48] . 329

In addition to the effects of cytokine storms, the NF-κB pathway correlates with the 330 severity of metabolic syndrome in patients with COVID-19 [49] . High levels of glucose and 331 free fatty acids associated with chronic inflammation lead to diabetes mellitus and obesity. 332

Glucolipotoxicity occurring simultaneously with inflammatory responses stimulates the 333 noncanonical NF-κB pathway [50] . Under the effects of insulin resistance, glycogen synthase 334 and citrullinated H3 (citH3), which are the degradation products of fibrin or NETs [53] . The 350 antimicrobial proteins MPO and NE released from activated neutrophils have been 351 discovered in NETs [53] . The aggregation of NETs in clots obstructs lung microvessels and 352 other organs in patients with COVID-19 [53] . Although ACE2 is not expressed on neutrophils, 353 numerous ACE2 receptors are expressed on the vascular endothelial cells that are next to 354 the alveolar epithelial cells in the lung [53] . Vascular endothelial cells damaged by SARS-CoV-355 2 infection provoke neutrophil attraction and NET formation [53] . On the other hand, SARS-356

CoV-2 infection suppresses the expression of antioxidative transcription factors, such as 357 nuclear factor erythroid-related factor 2 (Nrf2), for the antioxidant response [54] . In 358 addition, SARS-CoV-2 may cause reactive oxygen species (ROS)-dependent NET formation 359 [53] . Injury to vascular endothelial cells promotes coagulation and the secretion of DAMPs, 360 which in turn lures activated platelets and neutrophils to aggregate on the surface of 361 damaged endothelial cells to ultimately form lytic NETs from neutrophils [53] . Finally, NETs 362 activate platelets and fibrin to accelerate immunothrombus formation to eliminate 363 pathogens and protect endothelial integrity [53] . (Platycodi radix) [8, 11] . After the above herbs are decocted, they are concentrated into an 372 extract and added to microcrystalline cellulose and maltodextrin to generate a powder. 373

Finally, 9 g of this Chinese patented medicine was obtained. In addition, an RCT of JSHD as 374 an adjuvant treatment to patients with COVID-19 infection is ongoing [11] . In Table 1 , we list 375 the English name, Latin name, family, species, dosage, and functions according to the TCM 376 patterns of each herb in JSHD. To adults, JSHD was orally administered 3 g (one packet) once 377 to three times a day. 378

This review intends to discuss the detailed mechanism of JSHD as an adjuvant COVID-19 379 treatment for future clinical use and experimental reference. The relevant research and 380 mechanism of all of the JSHD herbs or their active ingredients are summarized in Table 2 and 381 Figure 2 and will be described in detail below. 382

A. indica, known as Yu Jen Cao in Taiwan, is a traditional anti-inflammatory herb used 384 for the treatment of many diseases, including inflammatory skin diseases, liver disease, 385 gastrointestinal disease, hypertension, and immune system deficiencies [55] [56] [57] . Recently, a 386 study demonstrated that A. indica had anti-inflammatory effects against murine peritoneal 387 macrophages [58] . The active compounds of A. indica were found in the chloroform and n-388 butanol fractions of the methanol extract. A total of fourteen compounds were identified, 389 including pedalitin, asigenin, ovatodiolide, methylgallate, 3,4-dihydroxy benzoic acid, 390 scutellarein 7-O-β-D-glucuronide methyl ester, apigenin 7-O-glucuronide, calceolarioside, 391 cistanoside F, betonyoside A, campneoside II, acteoside, isoacteoside and terniflorin. The 392 invading pathogens induce innate immunity via the production of inflammatory mediators, 393 such as NO, TNF-α and IL-12. However, the overproduction of macrophage-derived 394 mediators may cause the injury of normal cells, further leading to inflammatory diseases 395 [58] . All extracts suppressed the production of NO radicals and the secretion of 396 proinflammatory cytokines (TNF-α and IL-12) induced by lipopolysaccharide (LPS)/IFN-γ in a 397 dose-dependent manner [58] . Among these, ovatodiolide most significantly inhibited the 15 enhanced production of NO, TNF-α and IL-12, followed by pedalitin, scutellarein 7-O-β-D-399 glucuronide methyl ester and acteoside [58] . Moreover, ovatodiolide, pedalitin and 400 scutellarein 7-O-β-D-glucuronide methyl ester most significantly induced G0/G1 stage arrest 401 of mitogen Con-A-stimulated spleen cells, suggesting that the inhibition of these 402 inflammatory mediators was associated with a cell cycle arrest in response to the 403 administration of these compounds [58] . Additionally, other findings showed the potent 404 anti-inflammatory properties of A. indica, which may alleviate the uncontrolled release of 405 pro-inflammatory cytokines in response to COVID-19 infection [57] . 406

A. argyi folium is a therapeutic herb that is widely distributed in the Northern 408

Hemisphere [59] . It has been used to treat patients with abdominal pain, dysmenorrhea, and 409 inflammation [60] . Previous research has demonstrated that A. argyi folium not only has 410 antioxidant [61] , antidiabetic [62] , anticancer [63] [64] , antimicrobial [65] , and antiulcer 411 activities [66] but also has anti-inflammatory [67] and antiallergic properties [68] . Although 412

there have been no studies on the effectiveness of A. argyi folium to treat COVID-19, a 413 previous study reported that A. argyi folium strongly inhibits inflammation [67] . counts, levels of IL-4, IL-5, and IL-13, and ovalbumin-specific IgE in asthmatic animals [69] . 424

Asthmatic animals had extensive inflammatory cell accumulation in perivascular and 425 peribronchial and mucus hypersecretion, which was diminished by A. argyi folium and DA 426 treatment [69] . The study reported that Erk mediated cytokines expression, such as IL-5, for 427 the regulation of IgE switching and eosinophil activation [69] . Erk was phosphorylated during 428 inflammatory responses and subsequently phosphorylated Erk induced various 429 inflammatory mediators, such as matrix metallopeptidase 9 (MMP-9) secreted by degraded collagen to exacerbate airway inflammation [69] . The study revealed that A. argyi 432 folium and DA treatment significantly reduced Erk phosphorylation and the expression of 433 MMP-9 in asthmatic animals [69] . 434

Another study displayed that the essential oil from A. argyi (AAEO) was composed of 435 17 components, including monoterpenes, sesquiterpenes, alcohols, and aromatic 436 compounds, and among which, the major components were cineole, camphor, α-(-)-thujone, 437 and borneol [70] . C. flos, documented as Ju Hua, has been widely used in TCM for its benefits to the 458 lungs, liver, and kidneys [72] , heat and toxin cleaning, and eyesight improvements [8] . reported to possess pharmacological effects to combat cytokine storms. [77, 78] . A study 474 investigated the protective effects of luteolin in injury-induced inflammation in rats and 475 found that after treatment with luteolin, serum levels of IL-1β, IL-6, and TNFα, i.e., 476 proinflammatory cytokines, were significantly reduced [79] . Moreover, flavonoids are widely 477 recognized as inhibitors of platelet function. Luteolin and another flavonoid, apigenin, found 478 in C. flos, have been identified to have antithrombotic efficacy. An in vitro human platelet 479 aggregation study revealed that these two compounds efficiently inhibited thromboxane A2 480 (TXA2) synthesis and collagen-induced platelet aggregation, exerting positive effects to treat 481 or prevent thrombotic events [80] . G. radix, also known as licorice in English and Gan Cao in Chinese, is commonly used not 505 only in TCM prescriptions but also in food preparation for desserts and cuisines [84] . A study 506 has shown that licorice is surprisingly one of the top 10 main ingredients used in TCM 507 prescriptions for COVID-19 [84] . According to the Chinese Pharmacopeia, licorice has been 508 categorized in the Qi reinforcement segment. It can replenish Qi (crucial energy that moves 509 within the body to sustain one's health), tonify the spleen, eliminate heat, diminish toxicity, 510 eradicate phlegm, relieve coughs, spasms, and pain, and harmonize other herbs in a single 511 prescription [85] . Experimental and clinical studies have demonstrated that licorice or G. 512 radix possesses antiviral, anti-inflammatory, immunomodulatory, antimicrobial, antitussive, 513 and expectorant activities [84] [85] [86] . 514

Licorice has been reported to attack SARS-CoV-2 directly by blocking its entry [86] . For 515 example, the molecular docking and network pharmacology approach confirmed that 516 licorice glycoside E can inhibit 3CLpro to block SARS-CoV-2 replication by targeting 517 phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma (PIK3CG) and E2F 518 transcription factor 1 (E2F1) through the PI3K-Akt signaling pathway [87, 88] . Furthermore, 519 licorice phenol in Huashi Baidu decoction can bind to Mpro and ACE2, which could hinder 520 SARS-CoV-2 replication and block viral binding sites [89] . Glycyrrhizin, a main compound of 521 licorice, has been reported to have antiviral effects on SARS-associated coronaviruses 522 (CoVs), human immunodeficiency virus type 1 (HIV-1), and chronic hepatitis C virus [90, 91] . 523

This study revealed that the key antiviral mechanism of glycyrrhizin is the induction of 524 molecular docking analyses, a study suggested that glycyrrhizin could be a potential drug 527 formation [93] . The metabolic syndrome patients often have high levels of 541 lipopolysaccharide (LPS) in the blood [93] . The combination of COVID-19 and LPS promotes 542 NF-κB and cytokine activation, further inducing inflammation and even ARDS [93] . The study 543 showed that gycyrrhizic acid regulated NF-κB to attenuate inflammatory response induced 544 by LPS [93] . On the other hand, SARS-CoV-2 could infect intestinal epithelial cells and 545 patients accompanied with inflammatory bowel disease (IBD) had poor recovery [93] . 546

Gycyrrhizic acid was also found to suppress TNF-α activity to mitigate intestinal 547 inflammation and improve IBD [93] . 548

We have known that SARS-CoV-2 infection may damage brain nerves. The study 549 showed that gycyrrhizic acid had a powerful neuroprotective effect in neuroinflammation 550 and ischemic brain damage through activating anti-apoptotic mechanisms, regulating 551 PI3K/Akt signaling, and inhibiting HMGB1 activity [93] . 552 SARS-CoV-2 infection promotes the expression of activating transcription factor 2 553 (ATF2), resulting in activating pro-inflammatory genes and increasing inflammatory pain 554 [93] . Gycyrrhizic acid was reported to exert anti-inflammatory activity to alleviate 555 glycyrrhizin derivatives with N-acetylgycosamine introduced into the glycoside chain had 559 elevated anti-SARS-CoV activities [94] . SARS-CoV viruses are highly glycosylated in spike 560 proteins (S-protein), and the viruses enter host cells through S-protein binding to cellular 561 receptors [94] . In this study, they found that the binding of N-acetylgycosamine to the 562 carbohydrates of the S-proteins could impede viral entry [94] . Saururaceae. Traditionally, this plant is acknowledged as a treatment for various diseases, 566 including pneumonia, cough, severe acute respiratory syndrome, uteritis, acne, eczema, 567 stomach ulcers, and leukorrhea. H. herba cum radice is known for its power to constrain the 568 replication of a variety of viruses, such as SARS coronavirus, influenza neuraminidase, 569 dengue virus serotype 2, and herpes simplex. Its key ingredients, such as alkaloids and 570 flavonoids, have made H. herba cum radice for possible treatment due to its anti-571 inflammatory, anticancer, antioxidative, antiobesity, and antimicrobial activities [95] . 572

Tsai et al. designed an innovative traditional Chinese medicine formula, NRICM101, as a 573 COVID-19 treatment for a bench-to-bedside study. Heartleaf Houttuynia, one of the 574 ingredients in NRICM101, has been demonstrated to have the potential to inhibit TNF-α 575 production and block the binding of the SARS-CoV-2 spike RBD protein to ACE2 [96] . Das et 576 al. found that H. herba cum radice could significantly inhibit three SARS-CoV-2 replication 577 proteins, i.e., Mpro, papain-like protease (PLpro), and ADP ribose phosphatase (ADRP). This 578 study used gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-579 mass spectrometry (LC-MS) and screened out two phytocompounds from H. herba cum 580 radice, i.e., 6-hydroxyondansetron and quercetin, and then docked these compounds into 581 three SARS-CoV-2 receptor proteins. Their results indicate that 6-hydroxyondansetron shows 582 a higher binding affinity to Mpro and PLpro and passes all the required drug discovery rules 583 while quercetin binds to ADRP but shows less drug-like properties [95] . 584 3.6. Ophiopogonis radix 585 effects of nourishing yin, moisturizing the lung, tonifying the stomach, and promoting fluid 588 and therefore can be used to treat lung dryness and dry cough. In modern studies, the 589 components of O. Radix, including steroidal saponins, polysaccharides, and 590 homoisoflavonoids, have displayed numerous pharmacological properties, such as anti-591 inflammatory, antioxidative, and immunomodulatory activities [97] . reducing the viral load, thus showing a good antiviral effect as a potential herbal candidate 627 against SARS-CoV-2 [105] . It has been demonstrated that P. folium can effectively inhibit the 628 inflammatory response by inactivating the HMGB1 signaling pathway through in vivo and in 629 vitro studies [104] . There also is evidence that rosmarinic acid (RA), a primary compound of 630 P. folium, has antimicrobial, antioxidant, and anticancer effects by impeding HMGB1 release, 631 downregulating HMGB1-dependent inflammatory responses in human endothelial cells, 632 hindering HMGB1-mediated hyperpermeability and leukocyte movement in mice, and 633 decreasing sepsis-related mortality and cecal ligation and puncture (CLP)-induced HMGB1 634 release [104] . Furthermore, in LPS-stimulated RAW 264.7 cells, Wang found that P. folium, 635 containing 4 monoterpenoids and 15 alkaloids, could significantly inhibit the production of 636 the cytokines like TNF-α and/or IL-6 and inflammatory-related mediator NO [106] . 637 3.8. Platycodi radix 638 P. radix, the root of Platycodon grandiflorum (PG), has been identified as a traditional 639 medicine for lung and throat diseases, such as bronchitis, laryngitis, and tonsillitis, in East 640

Asia for a long time [107] . A recent study showed that platycodin D (PD), a glycosylated 641 triterpenoid saponin that is the major active natural component of Platycodi radix [108] , 642 exhibits a variety of pharmacological activities, including anti-inflammatory, anticancer, 643 antidiabetic, and antinociceptive properties [107] . 644 A novel study demonstrated that PD could redistribute the membrane cholesterol to 645 block two routes of SARS-CoV-2 entry, including lysosome-and TMPRSS2-driven SARS-CoV-2 646 entry, which are the main infection routes [109] . Prosapogenin D methyl ester (PrsDMe) 647 contained within PD inhibited the expression of the iNOS and cyclooxygenase-2 (COX-2) 648 caspase-3 and Bax was downregulated, while the expression of bcl-2 was significantly 652 restored [107] . Considering the pharmacological effects mentioned above, PG has great 653 potential as a treatment to prevent and improve the clinical outcomes of However, due to the lack of research on human subjects, more clinical trials focusing on 655 patient populations, efficacy and dosing are needed. 656 3.9. A comprehensive evaluation of the functions of the herbs in JSHD 657

We summarized the description of JSHD and plotted the efficacy of each of its 658 constituent herbs against COVID-19 in Figure 2 and compiled these data in Table 3. In Table  659 3, we divided the efficacies against COVID-19 into the following 5 categories: antiviral, 660 antioxidation, suppression of the overactivated immune system, anti-inflammation, and 661 attenuation of organ injury, and further subdivided these 5 categories into their detailed 662 mechanisms. We analyzed each ingredient in JSHD mentioned above according to their 663 detailed mechanisms. 664

Although the results of our study suggest that JSHD is a potential multi-target drug 666 candidate for the inhibition and treatment of COVID-19, our study has some limitations. 

Immune evasion of sars-cov-2 emerging variants: What have we learnt so far?

The direct evidence and mechanism of traditional chinese medicine treatment of

transmission, diagnosis, and treatment of coronavirus disease 2019 (covid-19): A review

Traditional chinese medicine decoctions significantly reduce the mortality in severe and critically ill patients with covid-19: A retrospective cohort study

Efficacy of phytochemicals as immunomodulators in managing covid-19: A comprehensive view

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (sars-cov-2)

Review on the potential action mechanisms of chinese medicines in treating coronavirus disease

Jing si herbal tea developed from compassion is full of blessings

Platycodin d, a natural component of platycodon grandiflorum, prevents both lysosome-and tmprss2-driven sars-cov-2 infection by hindering membrane fusion

The lesson of supplementary treatment with chinese medicine on severe laboratory-confirmed sars patients

Jing-si-herbal-tea accelerates sarscov-2 load reduction among covid-19 patients

Coronavirus envelope protein: Current knowledge

Persistence of serum and saliva antibody responses to sars-cov-2 spike antigens in covid-19 patients

Neutralizing epitopes of the sars-cov s-protein cluster independent of repertoire, antigen structure or mab technology

Platycodin d, a natural component of platycodon grandiflorum, prevents both lysosome-and tmprss2-driven sars-cov-2 infection by hindering membrane fusion

Downregulation of ace2 induces overstimulation of the renin-angiotensin system in covid-19: Should we block the renin-angiotensin system?

Angiotensin-converting enzyme 2 protects from lethal avian influenza a h5n1 infections

Angiotensin-converting enzyme 2 in lung diseases

Angiotensin-converting enzyme 2 protects from severe acute lung failure

Designing of improved drugs for covid-19: Crystal structure of sars-cov-2 main protease m(pro)

Assembly and entry of severe acute respiratory syndrome coronavirus 2 (sars-cov2): Evaluation using virus-like particles

Nf-kappab signaling in inflammation

Hmg-1 as a late mediator of endotoxin lethality in mice

Hmgb1 as a late mediator of lethal systemic inflammation

Hmgb1 is a therapeutic target for sterile inflammation and infection

Potential role of high mobility group box 1 in viral infectious diseases

Potential role of high-mobility group box 1 protein in the pathogenesis of influenza h5n1 virus infection

Anti-high mobility group box-1 monoclonal antibody treatment provides protection against influenza a virus (h1n1)-induced pneumonia in mice

Direct activation of endothelial cells by sars-cov-2 nucleocapsid protein is blocked by simvastatin

Elevated expression of serum endothelial cell adhesion molecules in covid-19 patients

Cytokine storm and leukocyte changes in mild versus severe sars-cov-2 infection: Review of 3939 covid-19 patients in china and emerging pathogenesis and therapy concepts

Neutralizing extracellular histones in acute respiratory distress syndrome. A new role for an endogenous pathway

Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy

Neutrophil extracellular trap (net) impact on Lachowicz-Scroggins ME

Extracellular DNA, neutrophil extracellular traps, and inflammasome activation in severe asthma

Immune cell profiling of covid-19 patients in the recovery stage by single-cell sequencing

Th17 responses in cytokine storm of covid-19: An emerging target of jak2 inhibitor fedratinib

Hmgb1-tlr4-il23-il17a axis promotes paraquat-induced acute lung injury by mediating neutrophil infiltration in mice

Interleukin-17: A potential therapeutic target in covid-19

The role of il-17 and related cytokines in inflammatory autoimmune diseases

Nitric oxide synthases: Regulation and function

Artemisia argyi attenuates airway inflammation in lipopolysaccharide induced acute lung injury model

Eosinophilic inflammation in allergic asthma

Pathophysiology of severe asthma: We've only just started

Inos inhibition reduces lung mechanical alterations and remodeling induced by particulate matter in mice

Nf-kappab, inflammation, and metabolic disease

The role and therapeutic potential of nf-kappa-b pathway in severe covid-19 patients. obesity and diabetes comorbidities: Is heat shock response determinant for the disease complications?

Vascular occlusion by neutrophil extracellular traps in covid-19

Immunothrombosis in severe covid-19

Metabolic implications of oxidative stress and inflammatory process in sars-cov-2 pathogenesis: Therapeutic potential of natural antioxidants

National Science Council of the Republic of China

Popular herbal remedies of taiwan

The constituents of anisomeles indica and their anti-inflammatory activities

Inhibition of pro-inflammatory mediators and tumor cell proliferation by anisomeles indica extracts

Polyphenol mixture of a native korean variety of artemisia argyi h.(seomae mugwort) and its anti-inflammatory effects

Artemisia argyi attenuates airway inflammation in lipopolysaccharide induced acute lung injury model

Flavonoids from artemisia annua l. As antioxidants and their potential synergism with artemisinin against malaria and cancer

Mugwort (artemisia vulgaris, artemisia douglasiana, artemisia argyi) in the treatment of menopause, premenstrual syndrome, isoscopoletin, the inhibitory active principles towards ccrf-cem leukaemia cells and multi-drug resistant cem/adr5000 cells, from artemisia argyi

Antitumor activity of flavones isolated from artemisia argyi

New sesquiterpene-monoterpene lactone, artemisolide, isolated from artemisia argyi

Separation of anti-ulcer flavonoids from artemisia extracts by high-speed countercurrent chromatography

Anti-inflammatory effects of artemisia leaf extract in mice with contact dermatitis in vitro and in vivo

Effects of eupatilin and jaceosidin on cytochrome p450 enzyme activities in human liver microsomes

Artemisia argyi attenuates airway inflammation in ovalbumin-induced asthmatic animals

Essential oil of artemisia argyi suppresses inflammatory responses by inhibiting jak/stats activation

Lactone ringopening seco-guaianolide involved heterodimers linked via an ester bond from artemisia argyi with no inhibitory activity

Chinese herbal medicines: Comparisons and characteristics e-book

The composition of chrysanthemum extracts and their pharmacological functions

Identification of the phenolic components of chrysanthemum flower (chrysanthemum morifolium ramat)

Luteolin: A blocker of sars-cov-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics

against the sars-cov-2 (covid-19) coronavirus by molecular docking

Flavonoids as potential phytotherapeutics to combat cytokine storm in sars-cov-2

Calming the storm: Natural immunosuppressants as adjuvants to target the cytokine storm in covid-19

Protective effects of luteolin on injury induced inflammation through reduction of tissue uric acid and proinflammatory cytokines in rats

Flavonoids inhibit platelet function through binding to the thromboxane a2 receptor

Casticin improves respiratory dysfunction and attenuates oxidative stress and inflammation via inhibition of nf-ĸb in a chronic obstructive pulmonary disease model of chronic cigarette smoke-exposed rats. Drug Design

Potential anti-viral activity of bio-active compounds of indigenous herbal plants against covid-19: A molecular docking study

Chlorogenic acid may be a potent inhibitor of dimeric sars-cov-2 main protease 3clpro: An in silico study

Commission CP. Pharmacopoeia of the people's republic of china (2015 edition) medical science and technology press

In silico screening of chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus

Review on the potential action mechanisms of chinese medicines in treating coronavirus disease 2019 (covid-19)

Xu with huashi baidu formula based on network pharmacology

Licorice: A potential herb in overcoming sars-cov-2 infections

Natural products and phytochemicals as potential anti-sars-cov-2 drugs

Recognition of natural products as potential inhibitors of covid-19 main protease (mpro): In-silico evidences

Glycyrrhizin, an active component of liquorice roots, and replication of sarsassociated coronavirus

Glycyrrhizic acid: A natural plant ingredient as a drug candidate to treat covid-19

Antiviral activity of glycyrrhizic acid derivatives against sarscoronavirus

Identification of phytocompounds from houttuynia cordata thunb. As potential inhibitors for sars-cov-2 replication proteins through gc-ms/lc-ms characterization, molecular docking and molecular dynamics simulation

A traditional chinese medicine formula nricm101 to target covid-19 through multiple pathways: A bedside-to-bench study

Ophiopogon japonicusa phytochemical, ethnomedicinal and pharmacological review

Antiinflammatory activities of ophiopogonis radix on hydrogen peroxide-induced cellular senescence of normal human dermal fibroblasts

Evaluation of antiinflammatory activity of compounds isolated from the rhizome of ophiopogon japonicas

Preventive effect of ophiopogon japonicus polysaccharides on an autoallergic mouse model for sjogren's syndrome by regulating the th1/th2 cytokine imbalance

The emerging threat of (micro) thrombosis in covid-19 and its therapeutic implications

Inhibitory effects of ethanol extract from radix ophiopogon japonicus on venous thrombosis linked with its endothelium-protective and anti-adhesive activities

Perilla (perilla frutescens) leaf extract inhibits sarscov-2 via direct virus inactivation

Barrier protective effects of rosmarinic acid on hmgb1-induced inflammatory responses in vitro and in vivo

Identification of existing pharmaceuticals and herbal medicines as inhibitors of sars-cov-2 infection

Antiinflammatory constituents from perilla frutescens on lipopolysaccharide-stimulated raw264. 7 cells

Platycodin d attenuates acute lung injury by suppressing apoptosis and inflammation in vivo and in vitro

Anti-inflammatory activity of prosapogenin methyl ester of platycodin d via nuclear factor-kappab pathway inhibition

Platycodin d, a natural component of platycodon grandiflorum, prevents both lysosome-and tmprss2-driven sars-cov-2 infection by hindering membrane fusion

Traditional medicine of nanning city. Nanning Institute of Traditional Chinese Medicine

Reduce cell apoptosis ✔ Promote anti-thrombosis ✔